Venous port catheter implantation for chemotherapy: Our experience in pediatric cases Port-catheter experiences in pediatric cases

Aim: The use of central venous access devices and especially venous port catheters is increasing day by day due to frequent venous Interventions and long-term and painful treatment in chemotherapy treatment of cancer patients. In this study, we aimed to evaluate the applications of chemotherapy port-catheters in pediatric patients. Material and Methods: Between 2014 and 2017, 76 pediatric cancer patients who were inserted venous port catheters for chemotherapy treatment in our hospital were evaluated retrospectively. Demographic data, diagnoses, port implantation site, and complications observed during and after the procedure were examined. The ports were placed under general anesthesia. Fluoroscopy was used during port placement, but not ultrasound. Results: The mean age of the patients was 6.88 +/- 4.79 (1-16) years and consisted of 31 (40.8%) female and 45 (59.2%) male patients. A chemotherapy portcatheter was inserted through the right subclavian vein in 48 patients, the left subclavian vein in 27 patients, and the right internal jugular win in 1 patient Five French (n=46; 60.5%), 6Fr (n=18; 23.7%) and 7Fr (n-12; 15.8%) port catheters were used for the number of patients involved. Arterial puncture was seen in 17 patients. Infection developed in 12 patients who received antibiotic therapy. Resorbed pneumothorax developed in one (1.3%) patient. No malposition was observed during the procedure. Discussion: Despite some complications that may occur during chemotherapy port-catheter implantation in patients who will receive chemotherapy, it is a preferred method in terms of patient comfort. It is recommended to use imaging methods during and after the procedure to reduce complications.